Method of classifying leukocytes by flow cytometry and reagents used in the method

Abstract: Methods for classifying leukocytes with a flow cytometer by means of optical measurements on fluorochrome-stained blood cells or those which have been so treated as to provide varying intensity in forward scattered light are useful in the practice of clinical testing. Also included are reagents employed in the practice of such methods.

Description: The present invention relates to a method for classifying leukocytes in the practice of clinical testing, and reagents used in such a method. More particularly, the present invention relates to a method for classifying leukocytes with a flow cytometer which have been treated so as to provide varying intensity in forward scattered light. The present invention also relates to reagents employed in the practice of such a method. Leukocytes in the peripheral blood of normal subjects can be classified as being of five types consisting of lymphocytes, monocytes, neutrophils, eosinophils, and basophils. Different leukocyte types have different functions and counting of leukocytes in the blood according to their type will provide valuable information for diagnostic purposes. For instance, an increase in the number of neutrophils is associated with such diseases as inflammations, myocardial infarction and leukemia, and a decrease in their number is associated with viral diseases, hypoplastic anemia, agranulocytosis, etc. On the other hand, an increase in the number of eosinophils is found in such diseases as parasitosis, Hodgkin's diseases and allergosis. An increased number of monocytes occurs either during the convalescence period of patients suffering from infectious diseases or in such diseases as monocytic leukemia. Classification and counting of leukocytes have been made most commonly by the differential counting method which is also referred to as the visual counting method or simply as the manual method. In this method, a blood sample is smeared on a glass slide and the blood corpuscles in the smear are fixed and stained for examination by microscopy. The technician identifies the type of individual leukocytes according to their morphological features (e.g., their size, the morphology of their nucleus and cytoplasm, and the presence or absence of granules) or the degree of dye uptake and performs classification and counting of them. At ordinary laboratories, 100 - 200 leukocytes are usually counted for each sample and the percentage of the total leukocyte count occupied by each type of corpuscle is recorded as a measured value. The differential counting method has several disadvantages. First, microscopic observation must be preceded by cumbersome procedures for preparing a specimen that involve such steps as smearing a blood sample on a glass slide, fixing the corpuscles and staining them. Secondly, it is a great burden for the technician to identify subtle differences between corpuscles by microscopic classification and counting. Thirdly, it is difficult even for a skilled technician to yield consistent counts by the manual method since aside from the small number of leukocytes computed, the smeared sample often has an uneven distribution of blood corpuscles. Various methods have been'proposed for eliminating these disadvantages of the manual method of leukocyte classification by achieving automation and such automated techniques may be roughly divided into two types. The first method consists of recording the images of corpuscles with a video camera or some other suitable imaging device and classifying the leukocytes by means of image processing on a computer. The operating principle of this method is similar to that of the conventional visual counting method but primarily due to the existence of many corpuscles that defy classification by processing with a computer, this method has not yet become an ideal alternative to the manual method. Furthermore, this method is not economically feasible since it requires sophisticated equipment which is large and costly. The other approach toward automatic classification and counting of leukocytes is based on a flow system. In this method, a blood sample having corpuscles suspended in a diluent is permitted to flow in such a way that the corpuscles will individually (one by one) pass through a constricted detector and leukocyte classification is made by analyzing the signal generated by the detector. This second method of leukocyte counting which makes use of a flow system is further subdivided into two categories. In a method of the first category, an electrolyte in which all red cells that were present have been destroyed with a lysing agent so that only leukocytes will be suspended is permitted to flow through an orifice and the change in electrical impedance that occurs at the orifice when each corpuscle passes through it is detected, with the magnitude of the detected signal being used as a basis for classification of leukocytes. A method of the second category is characterized by the use of a flow cytometer that comprises a light source, a flow cell that permits the blood cells in a sample to flow one by one through a constricted channel, a photometric unit that detects light issuing from each blood cell, and an analyzer for analyzing the detected signal. In this method, the corpuscles in the sample which are stained are illuminated under light and the fluorescence emitted from the irradiated corpuscles is detected, optionally together with soattered light, with leukocyte classification being made in accordance with the intensity of the detected signal. Techniques that fall within the category of this flow cytometric method are described in, for example, Japanese Patent Publication No. 853/1984 and L. A. Kamentsky, Blood, 6, 121 - 140 (1980). According to these techniques, a blood sample is stained with 10 volumes of an acridine orange solution, incubated for 1 minute, and irradiated under a light source such as an argon ion laser. The green fluorescence and red fluorescence that are emitted from the individual corpuscles are measured and classification and counting of leukocytes are subsequently made based on a two-dimensional plot of the fluorescence measurements. Other examples of techniques that are classified as being within the flow cytometric approach are shown in Unexamined Published Japanese Patent Application No. 20820/1975, H. M. Shapiro et al., J. Histochem. Cytochem., 24 (1) 395 - 411 (1976); and supra , 25 (8) 976 - 989 (1977). According to these methods, a blood sample is stained with 4 volumes of a Dye Solution I, incubated for 3 minutes, further mixed with 20% formaldehyde in a volume equal to the blood, fixed for 5 minutes, and diluted with a diluting Dye Solution II to obtain a concentration 15 - 20 times as low as the initial value. The so prepared specimen is subjected to measurement with a flow cytometer. The flow cytometer employed in the these methods uses either a mercury lamp that produces three different wavelengths of light or three lasers, so As to excite the three fluorescent stains in each of the dye solutions. The parameters measured are three kinds of fluorescence, forward scattered light, 90°C scattered light and absorbed light. Based on these six parameters, two-dimensional plots are constructed in four stages and analyzed to make leukocyte classification and counting. Japanese Patent Application No. 213715/1986 filed on September 10, 1986 discloses a one-step staining process consisting of staining a bldod sample with a dye solution comprised of a buffer solution, inbrganic salts and fluorescent stains. But this method has the problem that unlyzed erythrocytes may adversely affect measurement data to produce unreliable results. In the first version of the method that uses a flow system for leukocyte classification and counting, the disruption of erythrocytes is a prerequisite but depending on a blood sample, it is impossible to effect complete lysis of erythrocytes and the accuracy of measurements may be impaired in such a case. The examples of the flow cytometric approach that are described in Japanese Patent Publication No. 853/1984 and Blood Cells, 6, 121 - 140 (1980) are characterized by performing measurements before dye absorption by the cells reaches and equilibrium, or at the time when the difference between the intensities of fluorescence from individual leukocytes attains a maximum during the staining process. However, the time required for attaining an appropriate level of fluorescence intensity in a sample whose leukocyte count is at either one of two extremes will be different from the time for a normal sample and an appropriate staining time must be selected for each sample. As a further problem, this method relies solely on the differential-intensity of fluorescence for leukocyte classification and does not necessarily ensure precise separation between different leukocyte types such as lymphocytes and monocytes. The other examples of the cytometric approach that are described in Unexamined Published Japanese Patent Application No. 20820/1975, J. Histochem, Cytochem., 24 (1) 396 - 411 (1976) and supra , 25 (8) 976 - 989 (1977) have the disadvantage that they involve many steps of operation, take a prolonged staining time and require the use of reagents in a complex system. Furthermore, practice of these methods requires a very sophisticated and costly apparatus that includes three light sources and which is capable of measuring six parameters. In addition, analysis of such a large number of parameters is inevitably complicated and requires an analyzer of large capacity. All of the prior art techniques of flow cytometric approach including the method proposed by Japanese Patent Application No. 213715/1986 has one common problem in that detection with a flow cytometer is impossible if neutrophils in a blood sample become dead when a long time has passed before measurement. In order to avoid this problem, measurements by these flow cytometric methods always require the use of fresh blood samples. The present invention has been accomplished in order to solve the aforementioned problems of the prior art techniques for leukocyte classification and counting and it provides reagents and a method that enables accurate classification and counting of leukocytes by simple procedures. The present invention provides a method for classification and counting of leukocytes, namely, a method that is based on the measurement of a forward scattered light signal and a right-angle (or rectangular) scattered light signal. The method of the present invention comprises the following steps (a') to (d'): (a') a step of lysing the erythrocytes in a sample of anti-coagulated blood by adding it to a hypotonic first fluid composed of a material that selectively decreases the intensity of forward scattered light from eosinophils and basophils, and a buffer for maintaining an acidic pH range; (b') a step of initiating a leukocyte reaction by adding to the lysed blood sample a second fluid that is composed of a buffer for neutralizing the acid in the buffer in the first fluid and maintaining a pH suitable for leukocyte reaction, and an osmolarity compensating agent for adjusting the osmolarity of the resulting reaction solution to a value at which the leukocytes remain unchanged in shape; (c') a step of permitting the sample of flow through a flow cytometer and measuring the signals of forward scattered light and right-angle scattered light from leukocytes; and (d') a step of identifying the type of each of the leukocytes based on the forward scattered light and right-angle scattered light signals emitted therefrom, counting the number of detected leukocytes according to their type, and calculating the proportions of individual leukocyte types. In this method, a fluorochrome dye for staining the nuclei of leukocytes may be incorporated in the first fluid and step (c') may include the operation of identifying different types of leukocytes by intensity of fluorescence signal in order to extract forward scattered light and right-angle scattered light signals solely from the leukocytes. The reagent system for use in the classificiation of leukocytes into five types by flow cytometry in accordance with the present invention is composed of: (1) a substance that reduces forward scattered light, an example of such fluorochrome or substance being Astrazon Yellow 3G; and optionally (2) one of the following fluorochrome dyes that stain the nuclei of leukocytes: Acridine Red; Rhodamine S; Rhodamine 6G; Rhodamine B; Rhodamine 19 perchlorate; Rhodamine 123; Eosin Y; Cyanosine; Cresyl Fast Violet; Darrow Red; Acronol Phloxine FFS; 1,1'-dimethylthiocarbocyanine; 1,1'-diethylthiocarbocyanine; 1,1'-diethyl-9-methylthiocarbocyanine bromide; 2-[γ-1'-ethil-4',5'-benzothiazolylidene)propenyl]-1-ethyl-4,5-benzoxazolium iodide; Astrazon Red 6B; C.I. Basic Violet 16; 2-(p-dimethylaminostyryl)-1-ethyl-4,5-benzothiazolium iodide; 2,4-bis(p-dimethylaminostyryl)-1-ethyl-pyridnium iodide; 2,6-bis(p-dimethylaminostytryl)-1-ethyl-pyridnium iodide; TA-2 (Nippon Kankoh-Shikiso Kenkyusho Co., Ltd., Okayama, Japan); and Astrazon Orange R. The last-mentioned Astrazon Orange R is particularly preferred for use as component (2). Fig. 1 is a schematic diagram of the optics of a flow cytometer that may be employed in implementing the method of the present invention; Fig. 2 is a graph showing the excitation and fluorescence characteristics of Astrazon Yellow 3G; Fig. 3 is a graph showing the excitation and fluorescence characteristics of Astrozon Orange R; Fig. 30(a) is a two-dimensional plot of the intensities of fluorescence and right-angle scattered light as measured to classify leukocytes; Fig. 30(b) is a two-dimensional plot of the intensities of forward scattered light and right-angle scattered light as measured to classify leukocytes; Fig. 31(a) is a graph in which the fraction of lymphocytes shown in Fig. 30(a) is delineated; Fig. 31(b) is a graph representing only the signal assigned to that fraction of lymphocytes in terms of the intensities of forward scattered light and right-angle scattered light; Figs. 32(a), 33(a), 34(a) and 35(a) are graphs in which the fractions of monocytes, neutrophils, eosinophils and basophils shown in Fig. 30(a) are respectively delineated; Figs. 32(b), 33(b), 34(b) and 35(b) are graphs showing the respective four fractions in terms of the intensities of forward scattered light and right-angle scattered light; Fig. 36 shows the correlation between the visual counting method and the third method of the present invention which employs forward scattered light and right-angle scattered light to determine the percentage of lymphocytes in the leukocytes of interest; and Figs. 37 to 40 show the results of similar analyses of regression conducted for the percentages of monocytes, neutrophils, eosinophils and basophils, respectively. In accordance with the present invention, not only a forward and a right-angle scattering light signal but also optionally a fluorescence signal is produced from leukocytes. The fluorescence signal reflects the cytochemical characters of leukocytes and depending on the interaction between stains and individual leukocyte types, signals of different intensities are produced from the leukocytes. The right-angle scattering light signal reflects the structural information of an individual white cell. The larger the nucleus of a white blood cell and the more granules that are present in it, the greater light reflection will occur in the cell to produce more intense right-angle scattered light. A lymphocyte contains very few or no granucles, so the scattered light produced from the lymphocyte is the weakest of all leukocytes. On the other hand, a neutrophil contains many granules and has a large nucleus, so that it produces the most intense scattered light. Monocytes, eosinophils and basophils produce scattered light the intensity of which is intermediate between the intensities of scattered light from lymphocytes and neutrophils. The forward scattered light provides information about the internal state and size of blood cells, and in the third method of the present invention, the forward scattered light from eosinophils and basophils is attenuated so that it can be adapted to classification of leukocytes into five types. The relative intensities of fluorescence and right-angle scattered light from individual leukocytes are plotted in Fig. 30(a), and the relative intensities of forward scattered light and right-angle scattered light from the leukocytes are plotted in Fig. 30(b). Of the three kinds of light produced from leukocytes, fluorescence is the weakest and requires a highly sensitive photomultiplier tube for its measurement, which adds to the overall cost of the equipment. The right-angle scattered light is more intense than fluorescence and may be measured with a photomultiplier tube of relatively low sensitivity. The forward scattered light is very intense as compared with fluorescence and right-angle scattered light, so it does not require any light-receiving device of high sensitivity such as a photomultiplier tube; instead, it can be measured with a photodiode after being converged with a condenser lens. Therefore, as will be described below in detail, by combining a forward scattered light signal with a right-angle scattered light signal, leukocytes can be classified into five types with a simple and less costly apparatus. A specific example of the optics of a flow cytometer employed in the present invention is hereunder described with reference to Fig. 1. The optics shown in Fig. 1 is used in a flow cytometer designed for measuring forward scattered light, right-angle scattered light, and fluorescence. As will be shown later in Example 1, fluorescence is necessary in the method of the present invention if leukocytes are to be distinguished from all other corpuscles by a fluorescence signal. Fluorescence is not necessary if the two groups of corpuscles are distinguished from each other by forward scattered light. In Example 1, fluorescence measurement was necessary because it involved a comparison with a method of leukocyte classification based on the intensity of fluorescence. In Example 1, fluorescence was also used as a means for distinguishing leukocytes from other corpuscles. In Fig. 1, the optics generally indicated by 10 uses an argon ion laser 12 as a light source and it operates at a wavelength of 488 nm, producing an output of 10 mW. Light emitted from the laser 12 is converged by a cylindrical lens 16 and illuminates a blood sample flowing through a flow cell 14. When the stained leukocytes in the sample are irradiated with the laser light, they produce scattered light and fluorescence. The right-angle scattered light and the fluorescence are converged with a condenser lens 18 and pass through an aperture 20 to fall upon a dichroic mirror 22. The dichroic mirror 22 reflects the right-angle scattered light 24 and transmits the fluorescence 26. The right-angle scattered light 24 reflected from the dichroic mirror 22 is detected in a photomultiplier tube 28. The fluorescence 26 that has been transmitted through the dichroic mirror 22 passes through a color filter 40 and is detected by a photomultiplier 42. The remaining component of light from the light source 12 is simply transmitted through the flow cell 14 in the forward direction and the resulting forward scattered light 50 is blocked by a beam stopper 44 so that it will not directly encounter a photodiode 48. Light that passes through the beam stopper 44 is converged with a condenser lens 46 and is subsequently received by the photodiode 48. The color filter 40, photomultiplier tube 42 and dichroic mirror 22 are employed to perform fluorescence measurement for the purpose of providing a reference for comparison between the results of measurement with forward scattered light and right-angle scattered light and those of measurement with fluorescence and right-angle scattered light. Dichroic mirror 22 is positioned to separate fluorescence from right-angle scattered light so that the former can be measured as a reference. If it is necessary to measure only the right-angle scattered light, the photomultiplier tube 28 may be positioned immediately after the aperture 20. If fluorescence is not measured as a reference, the color filter 40, dichroic mirror 22 and the photomultiplier tube 42 which require high sensitivity of measurement can be entirely eliminated and the resulting equipment will be very simple in construction and can be fabricated at low cost. Erythrocytes produce scattered light having an intensity comparable to that of the scattered light emitted from leukocytes. Accordingly, erythrocytes can interfere with the counting of leukocytes. In this case, one may measure fluorescence and scattered light simultaneously and regard as leukocytes only the corpuscles that emit fluorescence having an intensity greater than a certain level. However, if coincidence of leukocytes and erythrocytes occurs, the scattered light from erythrocytes is superposed on the scattered light from leukocytes, thereby making accurate measurement of scattered light from the leukocytes impossible. The aforementioned problem associated with the interference by erythrocytes can be solved if they are eliminated from the blood sample by a suitable technique such as lysing but this idea has not been put to practice in the present art because of the absence of any erythrocyte-eliminating method, such as lysing, that matches the conditions of staining. There is no prior art technique that performs lysing of erythrocytes in preparation for the classification of leukocytes into five types by staining with fluorochrome dyes. Also, there is no technique available that successfully lyses only erythrocytes within one minute and which yet does not deteriorate the right-angle scattered light (morphological information) from Leukocytes. Blood samples for leukocyte counting that are free from erythrocytes are commonly prepared by the following methods: i) lysing of erythrocytes a) treatment with a surfactant: b) treatment with an ammonium salt (e.g. NHSCl); c) hypotonic treatment (at physiological pH) ii) separation d) centrifugation; e) sedimentation; f) others. The methods (a) to (e) are briefly described below: a) Treatment with a surfactant: This method inhibits subsequent staining and in addition to lysing of erythrocytes, it causes morphological changes in leukocytes such as the loss of nuclei, swelling and shrinking, thereby making it difficult to achieve 3-part differentiation of leukocytes by signals of scattered light. Furthermore, leukocytes in the sample treated with a surfactant will experience morphological changes with time. b) Treatment with an ammonium salt: This method inhibits subsequent staining. In addition, the ammonium salt does not have a great ability to lyse erythrocytes and a thick sample that is a 20-fold dilution of the whole blood is difficult to prepare by this method. Furthermore, it takes as many as 3 - 5 minutes to achieve complete lysis of erythrocytes by method b). c) Hypotonic treatment: This method leaves leukocytes intact while lysing erythrocytes by making use of the fact that leukocytes are more resistant than erythrocytes in hypotonic solutions. However, at a physiological pH and under conditions that cause complete lysis of erythrocytes, part of the leukocytes will be destroyed. d) Centrifugation, e) Sedimentation: Both methods have such disadvantages as cumbersome and lengthy procedures, and high incidence of leukocyte loss and fluctuations in fractionation ratio. In the method of the present invention, erythrocytes in a blood sample are disrupted by an acidic and hypotonic treatment such as to reduce the disturbance that occurs in the intensity distribution of right-angle scattered light on account of coincidence of red and white blood cells. As already mentioned, if a hypotonic treatment is performed in the physiological pH range, not only the erythrocytes but also some leukocytes will be destroyed. On the other hand, if a hypotonic treatment is performed in an acidic pH range, for example, at a pH between 2.0 and 5.0, leukocytes will remain intact and only erythrocytes will be disrupted. In this case, no morphological changes such as the loss of nuclei, swelling and shrinkage will occur in as leukocytes. The mechanism by which erythrocytes are selectively lysed is not clear but as erythrocytes are progressively lysed by hypotonic treatment, embrittlement of their membranes and acidic fixation of leukocytes will probably proceed under acidic pH conditions, with the result that only leukocytes which are more resistant than erythrocytes remain intact. As a result of this hypotonic treatment under acidic conditions, most of the erythrocytes become "ghosty" and only part of them is reduced to "fragments". As a consequence, the intensity of right-angle scattered light signals from erythrocytes is reduced to no more than a half to a third of the intensity of right-angle scattered light signals from lymphocytes, and the coincidence of red and white blood cells can be disregarded for practical purposes. Since not all of the erythrocytes are reduced to "fragments" by the hypotonic treatment under acidic conditions, it is difficult to discriminate erythrocytes from leukocytes solely on the basis of the intensity of scattered light signals. Therefore, as already mentioned, it is desirable to discriminate erythrocytes from leukocytes by the intensity of a fluorescence signal. Erythrocytes cannot be completely discriminated from leukocytes solely on the basis of the intensity of a right-angle scattered light signal but if the intensity of forward scattered light signals is used as a criterion as in the method of the present invention, leukocytes can be completely distinguished from erythrocytes or platelets that have been subjected to a hypotonic treatment under acidic conditions. In this case, corpuscles that produce forward scattered light signals having intensities greater than a certain level are picked up as leukocytes that are separate from erythrocytes, platelets or noise. The functions performed by the stains employed in the methods of the present invention are described hereinafter. Astrazon Yellow 3G (C.I. No. 48,055 or C.I. Basic Yellow 11) has the following chemical formula: The excitation and fluorescence characteristics of Astrazon Yellow 3G are shown in Fig. 2. This dye has an excitation maximum at 430 - 455 nm and a fluorescence maximum at 525 nm. Astrazon Yellow 3G binds with heparin, histamine, histone or protamine in eosinophils and basophils so as to stain granules deeply. This contributes greatly to reduction in the intensity of forward scattered light. Astrazon Orange R has the following chemical formula: (C.I. No. 48,040 or C.I. Basic Orange 22) The excitation and fluorescence characteristics of Astrazon Orange R are shown in Fig. 3. This dye has an excitation maximum at 490 nm and a fluorescence maximum at 520 nm. Leukocytes can also be classified into five distinct types based on the intensities of forward scattered light and right-angle scattered light as shown in Fig. 30(b). This is not possible even if a sample of leukocytes unstained with fluorochromes is classified by a prior art technique based on the measurements of the intensities of forward scattered light and right-angle scattered light. The present inventors have found that only when the intensities of forward scattered light from eosinophils and basophils are reduced can leukocytes be classified into five distinct types solely on the basis of the intensities of forward scattered light and right-angle scattered light. The compositions, pHs and osmolarities of the dye solutions employed in the method of the present invention are described below in detail. The present invention is hereunder described with reference to an example that was carried out under most preferred conditions. It should however be noted that this example is by no means intended to limit the present invention. Example 1 Reagents : 1) First fluid Astrazon Yellow 3G (substance capable of selective reduction in the intensity of forward scattered light from basophils and eosinophils) 385 ppm Astrazon Orange R (fluorochrome for staining the nuclei of leukocytes) 330 ppm Diglycolic acid/sodium hydroxide pH, 4.5; osmolarity, 50 mOsm/kg (buffer) 10 mM 2) Second fluid Tricin-sodium hydroxide (buffer) 300 mM Sodium chloride (osmolarity adjusting agent) 750 mM pH, 9.8 - 9.9; osmolarity, 2,200 mOsm/kg Reaction procedures : Eighteen parts by volume of the first fluid was added to 1 part by volume of EDTA 2K anti-coagulated blood. After agitation, the mixture was incubated at 25°C for 20 seconds. Thereafter, 2 parts by volume of the second fluid was added and, after agitation, the mixture was incubated at 25°C for 40 seconds. The finally attained reaction conditions were a pH of 8.6 - 8.7 and an osmolarity of 286 mOsm/kg (isotonic). Selection of filter and dichronic mirror : Dichronic mirror 22 510 nm (reflects wavelengths not longer than 510 nm and transmits any unreflected light) Color filter 40 520 nm (transmits wavelengths not shorter than 520 nm) Results of analyses : A two-dimensional plot of the intensities of fluorescence and right-angle scattered light as measured with a flow cytometer under the conditions described above is shown in Fig. 30(a). Leukocytes were successfully classified into five types. The fractions of the individual leukocyte types shown in Fig. 30(a) are classified in Fig. 30(b) according to the intensities of forward scattered light and right-angle scattered light. In obtaining the data shown in Figs. 30(a) and 30(b), discrimination of leukocytes from noise and from other corpuscles including their ghosts was achieved by means of a fluorescence signal. The fraction of lymphocytes shown in Fig. 30(a) is delineated in Fig. 31(a), and only the signal assigned to that fraction is represented in Fig. 31(b) by the intensities of forward scattered light and right-angle scattered light. In a similar manner, the fractions of monocytes, neutrophils, eosinophils and basophils shown in Fig. 30(a) are delineated in Figs. 32(a), 33(a), 34(a) and 35(a), respectively, and corresponding plots of the intensities of forward scattered light and right-angle scattered light for the respective fractions are shown in Figs. 32(b), 33(b), 34(b) and 35(b). The symbols and numerals used in Figs. 30 - 35 have the following meanings: FL, relative intensity of fluorescence; Side Sc., relative intensity of right-angle scattered light; Forward Sc., relative intensity of forward scattered light; 1, lymphocyte; 2, monocyte; 3, neutrophil; 4, eosinophil; 5, basophil. Fig. 36 shows the correlation between the third method of the present invention (i.e., based on measurement of the intensities of forward scattered light and right-angle scattered light) and the visual counting method when each method is applied to measure the percentage of lymphocytes in the leukocytes of interest. The percentage of lymphocytes counted by the visual method is plotted on the X-axis and that counted by the third method of the present invention is plotted on the Y-axis. The straight line in Fig. 36 is the regression line and the regression of Y upon X is estimated by the equation Y = 0.94935*X + 3.34446; r is the correlation coefficient and n is the number of samples. The results of similar analyses of regression conducted for the percentages of monocytes, neutrophils, eosinophils and basophils are graphed in Figs. 37 to 40, respectively. A good correlation is attained for all leukocyte types except basophils (Fig. 40). Because the absolute number of basophils in blood is small, the accuracy and reproducibility of the data attained by the visual method are inherently low and this is why there is no good correlation between the visual method and the third method of the present invention. In Example 1, the erythrocytes in the sample were lysed and fluorescence was used and these contributed to most efficient separation of leukocytes from all other corpuscles. Equally good results can be attained by using a forward scattered light signal. In this latter case, there is no need to use Astrazon Orange R as a dye for staining the nuclei of leukocytes. In addition, a simpler and less costly apparatus will do because it is not necessary to measure the intensity of fluorescence. In Example 1, all measurements are initiated after the necessary procedures of staining or reaction have been completed (namely, after staining or reaction has reached an equilibrium). Therefore, the sample will not experience any time-dependent change during measurements, and an appropriate level of the intensity of staining or reaction can be attained within a certain period of time no matter how large or small the number of leukocytes in the sample is. This allows for consistent results in measurement and a fluorescence signal of an adequate intensity can be attained even if a light source of a comparatively low output is used. In Example 1 described above, an argon ion laser of 10 mW was employed as a light source in the flow cytometer. However, the light source in the flow cytometer used in the present invention is not limited to the aforementioned argon ion laser of low output and any of the other light sources can be employed, such as a mercury arc lamp, xenon arc lamp, a He-Cd laser, a He-Ne laser and a Krypton ion laser, as well as an argon ion laser of high output. If these light sources are used, the conditions of staining, reaction and measurement may be selected as appropriate. The method of the present invention as applied to classify and count leukocytes in blood has the following advantages. (1) A sample for measurement can be prepared by simple preliminary treatments that involve only one step of staining (i.e., addition of anti-coagulated blood to a dye solution) or two-step staining or reaction (i.e., adding a first fluid to anti-coagulated blood, followed by addition of a second fluid). (2) The sample can be prepared in approximately 1 minute and this provides a rapid access time for measurement. (3) Since measurements are conducted after the necessary procedures of staining or reaction have been completed, the sample will not experience any time-dependent change during measurements and an appropriate intensity of staining or reaction can always be attained within a certain period of time irrespective of the nature of the sample (whether it is normal or contains an extremely large or small number of leukocytes). This eliminates the need to change the staining time from sample to sample. (4) Since measurements are conducted after staining has been completed to provide a high staining intensity, a light source of low output may be employed. In addition, only one light source need be used. The parameters to be measured are one channel of forward scattered light and one channel of right-angle scattered light. Because the number of parameters to be measured and analyzed is this few, the present invention can be implemented with a simple and inexpensive apparatus. (5) In the method, erythrocytes are selectively lysed by an isotonic treatment under acidic conditions. Since the coincidence of erythrocytes and leukocytes is eliminated by this treatment, a very efficient separation between lymphocytes, monocytes and neutrophils can be achieved by means of a right-angle scattered light signal. (6) The separation of leukocytes from other corpuscles is attained by means of the intensity of either fluorescence or forward scattered light. Therefore, correct measurements are ensured in the present invention even if not all erythrocytes have been reduced to fragments. (7) In accordance with the present invention, the number of dead neutrophilic cells can be counted, so the correct number of neutrophils can be attained even if the blood has been left to stand for a prolonged time after sampling. (8) The use of a dye (i.e., Astrazon Yellow 3G) that allows for selective staining of both basophils and eosinophils contributes to simplification of the staining procedures. (9) If fluorescence is not used in the method for the purpose of separating leukocytes from other corpuscles, the only parameters to be measured are the intensities of forward scattered light and right-angle scattered light. Since the intensity of fluorescence is very small, a photomultiplier tube of high sensitivity must be employed for its measurement and this adds to the overall cost of the measuring instrument. Right-angle scattered light is more intense than fluorescence and can be measured by a photomultiplier of comparatively low sensitivity. Forward scattered light is so intense that it can be satisfactorily measured with a photodiode. The present invention ensures accurate and highly reproducible measurements by counting no less than 10,000 leukocytes for each sample.

Claims: A method for classification of leukocytes by flow cytometry which comprises the following steps (a') to (d'): (a') a step of lysing the erythrocytes in a sample of anti-coagulated blood by adding it to a hypotonic first fluid composed of a material that selectively decreases the intensity of forward scattered light from eosinophils and basophils, and a buffer for maintaining an acidic pH range; (b') a step of initiating a leukocyte reaction by adding to the lysed blood sample a second fluid that is composed of a buffer for neutralizing the acid in the first fluid and maintaining a pH suitable for leukocyte reaction, and an osmolarity compensating agent for adjusting the osmolarity of the resulting reaction solution to a value at which the leukocytes remain unchanged in shape; (c') a step of permitting the sample to flow through a flow cytometer and measuring the signals of forward scattered light and right-angle scattered light from leukocytes; and (d') a step of identifyinig the type of each of the leukocytes based on the forward scattered light and right-angle scattered light signals emitted therefrom, counting the number of detected leukocytes according to their type, and calculating the proportions of individual leukocyte types. A method for classification of leukocytes by flow cytometry which comprises the following steps (a") to (d"): (a') a step of lysing the erythrocytes in a sample of anti-coagulated blood by adding it to a hypotonic first fluid composed of a material that selectively decreases the intensity of forward scattered light from eosinophils and basophils, a fluorochrome dye for staining the nuclei of leukocytes, and a buffer for maintaining an acidic pH range; (b") a step of initiating a leukocyte reaction by adding to the lysed blood sample a second fluid that is composed of a buffer for neutralizing the acid in the first fluid and maintaining a pH suitable for leukocyte reaction, and an osmolarity compensating agent for adjusting the osmolarity of the resulting reaction solution to a value at which the leukocytes remain unchanged in shape; (c'') a step of permitting the sample to flow through a flow cytometer, differentiating leukocytes from all other corpuscles by intensity of fluorescence, and measuring the signals of forward scattered light and right-angle scattered light from leukocytes; and (d") a step of identifying the type of each of the leukocytes based on the forward scattered light and right-angle scattered light signals emitted therefrom, counting the number of detected leukocytes according to their type, and calculating the proportions of individual leukocyte types. A method according to claim 1 or 2, wherein the material that selectively decreases the intensity of forward scattered light from eosinophils and basophils is Astrazon Yellow 3G. A method according to claim 2, wherein the fluorochrome dye for staining the nuclei of leukocytes is at least one member selected from the group consisting of the following dyes: Acridine Red; Rhodamine S; Rhodamine 6G; Rhodamine B; Rhodamine 19 perchlorate; Rhodamine 123; Eosin Y; Cyanosine; Cresyl Fast Violet; Darrow Red; Acronol Phloxine FFS; 1,1'-dimethylthiocarbocyanine; 1,1'-diethylthiocarbocyanine; 1,1' diethyl-9-methylthiocarbocyanine bromide; 2-[γ-1'-ethil-4',5'-benzothiazolylidene)propenyl]-1-ethyl-4,5-benzoxazolium iodide; Astrazon Red 6B; C.I. Basic Violet 16; 2-(p-dimethylaminostyryl)-1-ethyl-4,5-benzothiazolium iodide; 2,4-bis(p-dimethylaminostyryl)-1-ethyl-pyridinium iodide; 2,6-bis(p-dimethylaminostyryl)-l-ethyl-pyridinium iodide; TA-2 Astrazon Orange R. A reagent system for use in a method for the classification of leukocytes into five types based on the measurement of the intensities of forward scattered light and right-angle scattered light by flow cytometry which comprises a group of reagents, one of which is a material that selectively decreases the intensity of forward scattered light from eosinophils and basophils. A reagent system for use in a method for the classification of leukocytes into five types based on the measurement of the intensities of forward scattered light and right-angle scattered light by flow cytometry which comprises a group of reagents, one of which is a material that selectively decreases the intensity of forward scattered light from eosinophils and basophils and another of which is a fluorochrome dye for staining the nuclei of leukocytes. A reagent system according to claim 5 or claim 6, wherein the material that selectively decreases the intensivity of forward scattered light from eosinophils and basophils is Astrazon Yellow 3G. A reagent system according to claim 5 or claim 6, wherein the fluorochrome dye for staining the nuclei of leukocytes is at least one member selected from the group consisting of the following dyes: Acridine Red; Rhodamine S; Rhodamine 6G; Rhodamine B; Rhodamine 19 perchlorate; Rhodamine 123; Eosin Y; Cyanosine; Cresyl Fast Violet; Darrow Red; Acronol Phloxine FFS; 1,1'-dimethylthiocarbocyanine; 1,1'-diethylthiocarbocyanine; 1,1'-diethyl-9-methylthiocarbocyanine bromide; 2-[γ-1'-ethil-4',5'-benzothiazolylidene)propenyl]-1-ethyl-4,5-benzoxazolium iodide; Astrazon Red 6B; C.I. Basic Violet 16; 2-(p-dimethylaminostyryl)-l-ethyl-4,5-benzothiazolium iodide; 2,4-bis(p-dimethylaminostyryl)-l-ethyl-pyridinium iodide; 2,6-bis(p-dimethylaminostyryl)-l-ethyl-pyridinium iodide; TA-2 Astrazon Orange R.

Inventors: KURODA TOMOYUKI, MATSUDA SYOUHEI, SAKATA TAKASHI, KURODA, TOMOYUKI, MATSUDA, SYOUHEI, SAKATA, TAKASHI
Applicants: TOA MEDICAL ELECTRONICS, TOA MEDICAL ELECTRONICS CO., LTD.
Application year: 1987
Main classification: C12Q1
IPC codes: G01N15, G01N1, G01N33